Yakov Kogan is CEO at CLEVELAND BIOLABS INC (CBLI). They have made 1 open-market trade across 1 company since 2009, most recently 2012-06-26.
CIK 0001370084
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $3K since 2011, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CBLI | 17,377 | — |
Shares reported on the most recent Form 4, priced at the 2012-06-28 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CBLI | BUY | 2011-08-19 | 2011-08-22 | $2.29 | $3K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2010-05-03 | 2010-05-04 | $3.76 | $23K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2010-04-01 | 2010-04-05 | $3.51 | $14K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2010-03-01 | 2010-03-02 | $3.77 | $23K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2010-02-01 | 2010-02-02 | $3.95 | $24K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2010-01-04 | 2010-01-04 | $3.50 | $21K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2009-12-01 | 2009-12-02 | $3.75 | $23K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2009-11-02 | 2009-11-03 | $3.87 | $23K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2009-10-01 | 2009-10-02 | $4.11 | $25K | N/A | N/A | N/A |
| CBLI | SELL · 10b5-1 | 2009-09-01 | 2009-09-02 | $3.89 | $23K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.